Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M890Revenue $M281Net Margin (%)-13.1Altman Z-Score12.1
Enterprise Value $M792EPS $-1.2Operating Margin %-13.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-13.2Higher ROA y-yN
Price/Book6.710-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %--Current Ratio3.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-19.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-25.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M32.5ROIC % (ttm)-104.6Gross Margin Increase y-yN

Gurus Latest Trades with GHDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GHDXDavid Swensen 2013-03-31 Sold Out -2.8%$26.72 - $29.65
($28.5)
$ 27.34-4%Sold Out0
GHDXDavid Swensen 2012-12-31 Buy 2.8%$26.42 - $36.8
($30.13)
$ 27.34-9%New holding37,861
GHDXDavid Swensen 2011-03-31 Sold Out -0.93%$21.08 - $26.18
($23.29)
$ 27.3417%Sold Out0
GHDXDavid Swensen 2010-12-31 Buy 0.93%$13.18 - $23.52
($17.74)
$ 27.3454%New holding38,243
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GHDX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GHDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LIVINGSTON RANDALL SDirector 2016-01-13Sell1,250$32.14-16.65view
Cole G BradleyCOO 2016-01-12Sell4,000$31.69-15.46view
Vaughn James JChief Commercial Officer 2016-01-07Sell2,000$33.63-20.34view
Cole G BradleyCOO 2015-12-08Sell4,000$29.26-8.44view
Leber LauraChief Communication Officer 2015-12-07Sell4,200$29.33-8.66view
Vaughn James JChief Commercial Officer 2015-12-07Sell2,000$29.33-8.66view
Cole G BradleyCOO 2015-11-10Sell4,000$26.032.92view
Cole G BradleyCOO 2015-09-09Sell9,664$25.355.68view
Cole G BradleyCOO 2015-07-07Sell4,000$27.53-2.69view
Cole G BradleyCOO 2015-06-09Sell4,000$26.242.1view

Quarterly/Annual Reports about GHDX:

    News about GHDX:

    Articles On GuruFocus.com
    CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares Jul 13 2012 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Mar 16 2011 
    Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Mar 16 2011 
    Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Mar 14 2011 
    Genomic Health Inc. (GHDX) COO G Bradley Cole sells 2,500 Shares Mar 10 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Feb 14 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Jan 19 2011 

    More From Other Websites
    Genomic Health to Announce Fourth Quarter and Year-End 2015 Financial Results and Host Conference... Feb 03 2016
    Genomic Health, Inc. – Value Analysis (NASDAQ:GHDX) : January 19, 2016 Jan 19 2016
    Genomic Health, Inc. breached its 50 day moving average in a Bearish Manner : January 18, 2016 Jan 18 2016
    Day 3 of #JPM16: Low-risk hookups vs. big-dollar tie-ups, seat gouging and the space race Jan 13 2016
    Genomic Health Down on Bleak Preliminary Q4, '15 Results Jan 11 2016
    Genomic Health Announces Plans to Launch Liquid Biopsy Mutation Panel in 2016 Jan 11 2016
    Genomic Health downgraded by Piper Jaffray Jan 11 2016
    Genomic Health Announces Preliminary 2015 Revenue and Confirms 2016 Growth Expectations Jan 08 2016
    GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 08 2016
    Genomic Health Announces Preliminary 2015 Revenue and Confirms 2016 Growth Expectations Jan 08 2016
    Genomic Health Upgraded By Canaccord, $44 Per Share Target Predicted Jan 06 2016
    Genomic Health to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 04 2016
    Genomic Health to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 04 2016
    Genomic Health (GHDX) Shows Strength: Stock Gains 8.2% Dec 21 2015
    New "Big Data" Brings Total Number of Breast Cancer Patients Studied to 50,000, Demonstrating... Dec 15 2015
    Genomic Health Announces Presentation of Eight Oncotype DX® Studies at the 2015 CTRC-AACR San... Dec 09 2015
    GENOMIC HEALTH INC Financials Dec 08 2015
    Is Genomic Health, Inc. (GHDX) A Good Stock To Buy? Nov 22 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK